{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:08:38Z","timestamp":1791443318125,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Natural Sciences and Engineering Research Council of Canada (NSERC)","award":["386396"],"award-info":[{"award-number":["386396"]}]},{"name":"the Suicide Study Network of the Fonds de recherche en sant\u00e9 du Qu\u00e9bec (FRSQ)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.parkreldis.2011.05.012","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T12:11:04Z","timestamp":1309003864000},"page":"593-598","source":"Crossref","is-referenced-by-count":91,"title":["Serotonin and dopamine striatal innervation in Parkinson\u2019s disease and Huntington\u2019s chorea"],"prefix":"10.1016","volume":"17","author":[{"given":"Catherine","family":"B\u00e9dard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9e","family":"Wallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2011.05.012_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","article-title":"Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib5","series-title":"Atlas of the human brain","author":"Mai","year":"2008"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.2006.04430.x","article-title":"Dopaminergic neurons intrinsic to the striatum","volume":"101","author":"Huot","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(87)91506-X","article-title":"Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington\u2019s disease striatum","volume":"416","author":"Ferrante","year":"1987","journal-title":"Brain Res"},{"issue":"Pt 3","key":"10.1016\/j.parkreldis.2011.05.012_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib9","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington disease","volume":"54","author":"Bohnen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington\u2019s disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/brain\/97.1.457","article-title":"Huntington\u2019s chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia","volume":"97","author":"Bird","year":"1974","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-4159.1976.tb04437.x","article-title":"Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"26","author":"McGeer","year":"1976","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/BF01487648","article-title":"Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in\u00a0patients with Parkinson\u2019s syndrome","volume":"39","author":"Bernheimer","year":"1961","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.10343","article-title":"Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications","volume":"18","author":"Calon","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib18","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(85)90473-X","article-title":"High and low affinity [3H]imipramine binding sites in control and parkinsonian brains","volume":"117","author":"Cash","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.36.4.556","article-title":"Parkinson\u2019s disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen","volume":"36","author":"Raisman","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(93)90240-G","article-title":"Serotoninergic terminal transporters are differentially affected in Parkinson\u2019s disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram","volume":"54","author":"Chinaglia","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000048698","article-title":"Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum","volume":"23","author":"Yamazoe","year":"2001","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)90363-E","article-title":"Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine","volume":"569","author":"Descarries","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.04.019","article-title":"Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA","volume":"1046","author":"Maeda","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(98)00198-0","article-title":"Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice","volume":"245","author":"Rozas","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00230443","article-title":"Serotonergic sprouting in primate MTP-induced hemiparkinsonism","volume":"96","author":"Gaspar","year":"1993","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib27","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1097\/00001756-199711100-00014","article-title":"Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats","volume":"8","author":"Guerra","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","article-title":"Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias","volume":"172","author":"Carta","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ana.22097","article-title":"Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia","volume":"68","author":"Rylander","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2011.05.012_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(87)90639-2","article-title":"Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington\u2019s disease brain","volume":"78","author":"Reynolds","year":"1987","journal-title":"Neurosci Lett"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T01:57:05Z","timestamp":1712541425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802011001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1353802011001441"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.05.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}